Loading clinical trials...
Loading clinical trials...
To determine whether the combination of ezetimibe and simvastatin improves biomarkers of atherothrombosis compared to simvastatin alone in patients with the metabolic syndrome.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Maryland, Baltimore
Collaborators
NCT06277661 · Postpartum Depression, Postpartum Anxiety, and more
NCT07547098 · Cardiovascular Diseases (CVD), Chronic Kidney Disease, and more
NCT07540949 · Obesity, Metabolic Syndrome
NCT06003686 · Spinal Cord Injuries, Obesity, and more
NCT07401888 · Metabolic Syndrome
VA Maryland Health Care System
Baltimore, Maryland
University of Maryland Medical Center
Baltimore, Maryland
Johns Hopkins Hospital
Baltimore, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions